Ad
related to: postmenopausal medication for breast cancer- Supportive Care
Browse Supportive Care Live Events.
Check Details.
- Grand Rounds
Explore the Available Resources
To Get Helpful Insights.
- Event Calendar
Explore the Calendar To Know About
The Upcoming Events.
- Press
Check Our Press Releases And
View More Details.
- Supportive Care
Search results
Results from the WOW.Com Content Network
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1] [2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women. [1]It was patented in 1986 and approved for medical use in 1996. [4]
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. [3]
Observational studies of systemic HRT after breast cancer are generally reassuring. If HRT is necessary after breast cancer, estrogen-only therapy or estrogen therapy with a progestogen may be safer options than combined systemic therapy. [71] In women who are BRCA1 or BRCA2 mutation carriers, HRT does not appear to impact breast cancer risk. [72]
Toremifene, sold under the brand name Fareston among others, is a medication which is used in the treatment of advanced breast cancer in postmenopausal women. [4] [6] [3] It is taken by mouth. [4] Side effects of toremifene include hot flashes, sweating, nausea, vomiting, dizziness, vaginal discharge, and vaginal bleeding.
The treatment saved my life but also pushed me into medically-induced menopause at the age of just 37. By this visit, my cancer was thankfully in remission and I was going to live to see my two ...
Fulvestrant, sold under the brand name Faslodex among others, is an antiestrogenic medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with abemaciclib or palbociclib in women with disease progression after endocrine therapy. [2]
Olivia Munn is looking at the road ahead in her breast cancer journey. The "Newsroom" actress, 44, shared that she has "years" to go in her breast cancer treatment while delivering remarks at Time ...
Ad
related to: postmenopausal medication for breast cancer